US · Healthcare

Estrella Immunopharma Inc. (ESLAW)

Biotechnology

Estrella Immunopharma Inc. (ESLAW) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ESLAW

P/E ratio

18.00

Estrella Immunopharma Inc. (ESLAW) — FAQ

What is ESLAW's P/E ratio?

The price-to-earnings (P/E) ratio for Estrella Immunopharma Inc. (ESLAW) is 18.00 (data as of 2026-03-24).

Does Estrella Immunopharma Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Estrella Immunopharma Inc. (ESLAW). Check the MyAverix Finance app for the latest dividend data.

What sector is Estrella Immunopharma Inc. in?

Estrella Immunopharma Inc. (ESLAW) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ESLAW listed on?

ESLAW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)